Biography
Dr. Jennifer W. Carlisle is an Assistant Professor of Hematology and Medical Oncology at Winship Cancer Institute of Emory University in Atlanta, Georgia. She is one of the few medical oncologists in the Southeast United States with a dedicated focus on mesothelioma, specializing in immunotherapy-based treatment approaches. Dr. Carlisle's research centers on immune checkpoint inhibitors and novel combination therapies for malignant pleural mesothelioma. Her presence at Winship provides patients across Georgia and the broader Southeast access to specialized mesothelioma medical oncology care at an NCI-designated comprehensive cancer center.
Education & Training
- Medical Degree — Emory University School of Medicine (Medicine)
- Residency — Emory University (Internal Medicine)
- Fellowship — Emory University / Winship Cancer Institute (Hematology and Medical Oncology)
Specialties & Procedures
Clinical Specialties
- Medical Oncology
- Thoracic Oncology
- Immunotherapy
As a medical oncologist, Dr. Jennifer W. Carlisle focuses on non-surgical treatment modalities including chemotherapy, immunotherapy, targeted therapy, and clinical trials.
Board Certifications
- American Board of Internal Medicine — Medical Oncology
- American Board of Internal Medicine — Internal Medicine
Research Focus
Immunotherapy for malignant pleural mesothelioma, immune checkpoint inhibitors in thoracic malignancies, and novel combination treatment strategies.
Treatment Center
Dr. Jennifer W. Carlisle practices at Winship Cancer Institute in Atlanta, GA.
Legal Resources for Mesothelioma Patients
Patients diagnosed with mesothelioma after asbestos exposure may be eligible for compensation through asbestos trust funds and legal claims. Over $30 billion remains available in trust funds nationwide.
Frequently Asked Questions
Does Dr. Carlisle specialize in mesothelioma immunotherapy?
Yes. Dr. Carlisle focuses on immunotherapy-based treatment strategies for malignant pleural mesothelioma, including immune checkpoint inhibitors and combination therapies. She is one of the few mesothelioma-focused medical oncologists in the Southeast.